Dephosphorylation of cAMP-dependent protein kinase regulatory subunit (type II) by calmodulin-dependent protein phosphatase. Determinants of substrate specificity. by Blumenthal, Donald K. & Takio, Koji
T h e  J o u r n a l  o f  B io l o g ic a l  C h e m is t r y  
© 1986 by The American Society of Biological Chemists, Inc.
Vol. 261, No. 18, Issue of June 25, pp. 8140-8145,1986 
Printed in U. S. A.
Dephosphorylation of cAMP-dependent Protein Kinase Regulatory 
Subunit (Type II) by Calmodulin-dependent Protein Phosphatase
DETERMINANTS OF SUBSTRATE SPECIFICITY*
(Received for publication, September 3,1985) 
Donald K. Blum enthalf, Koji Takio, R. Scott Hansen, and Edwin G. Krebs§









Calmodulin-dependent protein phosphatase purified 
from bovine cardiac muscle catalyzed the rapid de­
phosphorylation of Ser-95 of bovine cardiac cAMP- 
dependent protein kinase regulatory subunit (R h). The 
kinetic constants determined for the reaction (Km = 2 0  
hm; Vmax = 2 fimol min-1 mg-1) are comparable to those 
determined for other good substrates o f this phospha­
tase. Because little is known about the determinants of 
substrate specificity for the calmodulin-dependent 
phosphatase, various phosphopeptides were used to in­
vestigate the structural features important for sub­
strate recognition. Limited proteolysis of phospho-Rn 
with trypsin and chymotrypsin yielded fragments (res­
idues 93—400 and 9 1 -4 0 0 , respectively) that were 
poor substrates, whereas digestion with Staphylococ­
cal aureus V8 protease produced three phosphopep­
tides that were all dephosphorylated as rapidly as in­
tact Rn. The sequence of the shortest phosphopeptide 
produced by S. aureus V8 protease was determined by 
sequence analysis to be Asp-Leu-Asp-Val-Pro-Ile-Pro- 
Gly-Arg-Phe-Asp-Arg-Arg-Val-Ser-Val-Cys-Ala-Glu, 
corresponding to residues 81—99 of Rn. Synthetic phos­
phopeptides corresponding to residues 8 1 -9 9 , 8 5 -9 9 , 
90—99, and 91—99 were prepared to determine the 
minimum sequence necessary for substrate recogni­
tion. Only the 19-residue peptide (81 -99) was dephos­
phorylated with kinetics comparable to R n (Km = 26  
jtM, Vmax= 1.7 /tmol min-1 mg-1). Structural analysis of 
this peptide indicates that an amphipathic /3-sheet 
structure may be an important structural determinant 
for some substrates of the calmodulin-dependent phos­
phatase.
Protein phosphorylation is known to be an important bio­
chemical mechanism for the regulation of numerous physio­
logical processes (reviewed in Ref. 1). The extent of phospho­
rylation of a given phosphoprotein depends upon the activities 
of both the protein kinase (s) and protein phosphatase (s) that 
catalyze the respective phosphorylation and dephosphoryla­
tion reactions. Cohen and co-workers (2, 3) have recently 
described a calmodulin-dependent phosphoprotein phospha­
tase that was purified to homogeneity from rabbit skeletal 
muscle. Work by that group and others indicates that this
* The costs of publication of this article were defrayed in part by 
the payment of page charges. This article must therefore be hereby 
marked “advertisement” in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
|  Supported as a postdoctoral fellow of the Muscular Dystrophy 
Association. Present address: Dept, of Biochemistry, University of 
Texas Health Center, Tyler, TX 75710.
§ To whom correspondence should be addressed.
enzyme is found in many other tissues, most notably brain, 
where the enzyme was shown to be identical to the calmodu­
lin-binding protein known as calcineurin1 (2, 4-6). The en­
zyme was found to have a very narrow substrate specificity 
compared to other known protein phosphatases (2, 3). Be­
cause of a report showing that calcineurin binds tightly to 
type II cAMP-dependent protein kinase from brain via the 
type II regulatory subunit (Rn2; Ref. 7), the possibility that 
bovine cardiac calmodulin-dependent protein phosphatase 
might catalyze the dephosphorylation of autophosphorylated 
Rn from heart was investigated. The calmodulin-dependent 
phosphatase was found to rapidly dephosphorylate this sub­
strate in vitro. This report describes this reaction, various 
factors which influence the reaction, and in particular, the 
features of Rn structure important for recognition as a sub­
strate by the phosphatase.
MATERIALS AND METHODS
Preparation of Cardiac Calmodulin-dependent Protein Phospha­
tase—Calmodulin-dependent protein phosphatase was purified from 
fresh bovine heart ventricles following a modified procedure for cyclic 
nucleotide phosphodiesterase purification (8, 9). About 25 kg of 
ventricle was ground and then homogenized using buffer (2.5 liter/kg 
tissue) containing 40 mM Tris-Cl, pH 8.6,15 mM 2-mercaptoethanol,
0.1 mM phenylmethylsulfonyl fluoride. The homogenate was centri­
fuged (5000 X  g) and filtered through glass wool; the supernatant was 
adjusted to pH 8.0 with 5 N NaOH, and phenylmethylsulfonyl fluoride 
was added (0.3 mM final). The extract was then batch-adsorbed to 
approximately 8 liters (packed volume) of DEAE-cellulose (Whatman 
DE52, equilibrated in 20 mM Tris-Cl, pH 8.0) by gently stirring for 
30-40 min. The slurry was filtered and washed with 80-100 liters of 
20 mM Tris-Cl, pH 8.0, 1 mM MgCl2, 15 mM 2-mercaptoethanol, 0.1 
mM CaCl2, 0.1 M NaCl (buffer A) using gravity and aspirator suction. 
The DEAE-cellulose was mixed to a slurry (about 2 parts cellulose to 
1 part buffer) and placed in a large Buchner funnel (35 x  12 cm) 
fitted with wet-strengthened filter paper (Schleicher & Schuell). After 
careful packing, the “column” was further washed with 20 liters of 
buffer A (using gravity for packing and washing). Protein was eluted 
by addition of 4 mM EDTA (or 3 mM EGTA) to the wash buffer, and 
1-liter fractions were collected at a flow rate of 6-9 liters/h. The 
fractions were pooled on the basis of cyclic nucleotide phosphodies­
terase activity, which typically coeluted with calmodulin-dependent 
p-nitrophenylphosphatase activity. The pooled fractions (usually 4­
5 liters total volume) were adjusted to 0.4 mM phenylmethylsulfonyl 
fluoride and 5 mM MgCl2 (or 3 mM CaCl2). Packed calmodulin- 
Sepharose (about 100 g containing 0.3-0.5 mg of calmodulin/g or 50 
g containing 1-2 mg of calmodulin/g) pre-equilibrated in buffer A
1 The protein termed calmodulin-dependent protein phosphatase 
in this work has also been called protein phosphatase 2B, CaM-BPso, 
calcineurin, and modulator-binding protein.
2 The abbreviations used are: Rn, regulatory subunit of type II 
cAMP-dependent protein kinase; Mops, 3-(iV-morpholino) propane- 





























was added and gently stirred for 1-3 h. The resin was collected in a 
coarse scintered glass filter funnel (350 ml) and washed with 500 ml 
of buffer A. The filtrate and initial washes were combined and treated 
with additional calmodulin-Sepharose to adsorb any remaining cal­
modulin-binding proteins. A 1:1 slurry of the washed resin was loaded 
into a chromatography column (2.5-cm diameter) and washed further 
with buffer A until the eluent contained little protein (>0.01 fig/ml). 
Calmodulin-binding proteins were eluted with buffer A containing 1 
mM EGTA. The protein peak was pooled and stored at 4 °C. Two 
calmodulin-Sepharose adsorptions and elutions were usually neces­
sary to extract most of the calmodulin-binding proteins. The two 
pools were combined and usually contained 10-25 mg of protein. 
Cyclic nucleotide phosphodiesterase was removed from the calmod­
ulin-binding protein mixture using an anti-calmodulin antibody 
(ACAP-1 ) affinity column (10). The EGTA-eluted protein from the 
calmodulin-Sepharose column was mixed with purified calmodulin (1 
mg of calmodulin for every 2 mg of protein eluate) and adjusted to
1.5 mM CaCl2. The mixture was slowly applied to a column of ACAP-
1-Sepharose (1.5 x  8 cm, 10 mg of antibody/g of resin coupling 
density) or ACAP-l-Affi-Gel 10 (2 X  8 cm, 10-15 mg/g coupling 
density) which had been equilibrated in buffer A. Protein-containing 
fractions which did not bind to the antibody affinity column were 
pooled and used for calmodulin-dependent phosphatase purification. 
This material was reapplied to a fresh antibody affinity column to 
remove any remaining phosphodiesterase, then adjusted to 2 mM 
EGTA, diluted 2-fold with 20 mM sodium phosphate, pH 6.8, and 
applied to a column of DEAE-cellulose (0.7 X  5 cm equilibrated in 20 
mM sodium phosphate, pH 6.8, 0.05 M NaCl, 1 mM dithiothreitol, 0.2 
mM EGTA). The column was eluted with a linear gradient (50 ml) 
from 0.05 to 0.4 M NaCl. Calcineurin was conservatively pooled on 
the basis of analysis by polyacrylamide gel electrophoresis in the 
presence of sodium dodecyl sulfate. The yield was typically 2-5 mg 
of protein of which at least 90% was accounted for by the M, 15,000 
and 60,000 subunits of calcineurin. Sephacryl S-200 chromatography 
was used as an alternative fractionation procedure to the final DEAE- 
cellulose step and resulted in a similar preparation. The beef heart 
and brain subunits had similar electrophoretic mobilities except that 
the large subunit of the heart enzyme often appeared as a doublet in 
high resolution gels.
Preparation of Other Proteins and Peptides—Calmodulin was pre­
pared from fresh and frozen bovine testes using a procedure outlined 
previously (1 1 ). Fresh bovine cardiac muscle was used for purification 
of cAMP-dependent protein kinase catalytic subunit (12) and type II 
regulatory subunit (13). Synthetic peptides were prepared by using a 
Beckman 990 automated peptide synthesizer and standard solid- 
phase techniques (14). Cleavage and side-chain deprotection were 
effected by using HF containing 20% anisole for 45 min at 0 °C. 
Peptides were purified by ion-exchange chromatography (SP-Sepha- 
dex, Pharmacia) and gel filtration (G-10, Pharmacia). Peptide se­
quence was verified by amino acid analysis and Edman degradation. 
Peptide purity was greater than 95% as estimated by reversed-phase 
high performance liquid chromatography. Prior to phosphorylation, 
peptide concentrations were determined by amino acid analysis.
Preparation of Phospho-Ru and Pkosphopeptides—Ru and syn­
thetic peptides were radioactively labeled with 32P by incubating the 
protein or peptide with a 2-fold molar excess of [7 -32P]ATP (DuPont 
New England Nuclear, 200-400 cpm/pmol) and bovine cardiac 
cAMP-dependent protein kinase catalytic subunit (10-20 Mg/ml) in 
the presence of 20 mM Mops, pH 7.0, 2 mM magnesium acetate, 15 
mM /3-mercaptoethanol at room temperature. The time course of 
phosphorylation was followed using a filter paper technique (15). The 
substrate was usually completely phosphorylated within 30 min; if 
not, more catalytic subunit was added. A stoichiometry of 1  mol of 
phosphate/mol of substrate was verified by comparing the amount of 
phosphate incorporated with that expected based on the concentra­
tion of substrate used and the specific activity of radioisotope. In the 
case of Ru, the reaction mixture was placed in dialysis tubing in a 1 - 
liter Plexiglas chamber containing 15 mM /3-mercaptoethanol, 2 mM 
Mops, pH 7.0, at 4 °C. Voltage (~150 V) was applied across the 
chamber using 15-cm long platinum wire electrodes for 45-60 min. 
The buffer was changed and the process repeated three or four times 
before transferring the dialysis bag to a 4-liter container for overnight 
dialysis without applied current. The buffer for this last dialysis 
contained 20 mM Mops, pH 7.0,15 mM /3-mercaptoethanol. Nonpro­
tein bound radioactivity was determined by precipitating a sample of 
the dialyzed protein with 10% trichloroacetic acid in the presence of
0.5 mg/ml bovine serum albumin. The amount of radioactivity re­
maining in the supernatant following a 3-min spin in an Eppendorf
microcentrifuge was typically 1 % or less of the total radioactivity in 
the sample. The phosphoprotein sample thus prepared was stored at
4 °C until needed and showed no evidence of contaminating phospha­
tase activity. Synthetic phosphopeptide samples were treated with 
Dowex AG1-X8 as described by Wright et al. (16) to remove nonpep­
tide bound 32P. Nonpeptide bound radioactivity was usually 0.5% or 
less of the total radioactivity. Labeled phosphopeptides were stored 
at —20 °C until needed.
Phosphatase Assays—Dephosphorylation of phospho-Rn and phos­
phopeptides was determined in duplicate in 50-/J reaction volumes 
from which 20-/il samples were removed at two time points (usually
5 and 15 min) following initiation of the reaction. All reactions were 
performed at 30 °C in the presence of 50 mM Mops, pH 7.0, 2 mM 
magnesium acetate, 2 mM manganous acetate, 1 /uM calmodulin, 15 
mM /3-mercaptoethanol. Concentrations of other components were 
varied as required and are indicated where appropriate. Substrate 
concentration was determined by liquid scintillation counting using 
the specific radioactivity of the incorporated 32P label. The concen­
tration of phosphatase was adjusted to maintain linear rates of 
dephosphorylation with respect to time. All reactions included a 5- 
min preincubation before starting the reaction by addition of sub­
strate. Reactions involving Ru were terminated by transferring the 
aforementioned 20-/il reaction mixture samples to 1.5-ml conical 
plastic centrifuge tubes containing ice-cold 10% trichloroacetic acid. 
Bovine serum albumin was immediately added to a concentration of
0.5 mg/ml to facilitate precipitation. The samples were spun for 3 
min in an Eppendorf microcentrifuge and the supernatants counted 
to determine 32P released. The procedure described below for phos­
phopeptides was also employed and gave identical results. In the case 
of reactions involving phosphopeptides, the 20-jd samples of reaction 
were quenched by adding the samples to 1.5-ml centrifuge tubes 
containing 75 mM phosphoric acid and placing on ice. The quenched 
samples were applied to 0.5 ml of AG50W-X8 (Bio-Rad) as described 
by Wright et al. (16), and the unadsorbed material collected, and 
counted in a liquid scintillation counter to determine the amount of 
32P released.
RESULTS
Dephosphorylation of Intact Ru—Calmodulin-dependent 
protein phosphatase purified from bovine cardiac muscle cat­
alyzed the rapid dephosphorylation of autophosphorylated 
bovine cardiac Rn. Previous work has shown that autophos­
phorylation occurs at Ser-95 in this protein (17,18), and data 
obtained from limited proteolysis (described below) are con­
sistent with those reports. The kinetic parameters determined 
for the dephosphorylation reaction (Km and Vmax values of 20 
jtM, 2 nmol min-1 mg-1, respectively, were obtained in the 
presence of 2 mM Mn2+, 1 fiM calmodulin, at pH 7.0, and 
30 °C) are comparable to those reported for calmodulin-de­
pendent phosphatases purified from other tissues using sub­
strates such as protein phosphatase inhibitor-1 , myosin light 
chains, a-subunit of phosphorylase kinase, G-substrate, 
DARPP-32, and protein K.-F. (3,19). Although all of the data 
presented herein were obtained with phosphatase purified 
from heart, the calmodulin-dependent protein phosphatase 
purified from bovine brain also rapidly dephosphorylated 
cardiac Ru (data not shown). Indeed, the substrate specificity 
of the heart calmodulin-dependent phosphatase appears to be 
quite similar to calmodulin-dependent phosphatases purified 
from other tissues. The heart enzyme preferentially dephos- 
phorylates the a-subunit of phosphorylase kinase compared 
to the /3-subunit (42) and catalyzes the dephosphorylation of 
phosphorylase b at a rate that is approximately 50-fold lower 
than the rate of Rn dephosphorylation. These substrate pref­
erences are in accord with substrate specificities reported for 
the skeletal muscle enzyme (2, 3). Moreover, preparations of 
heart and brain enzyme showed similar patterns of substrate 
specificity when assayed with gizzard myosin light chains, p- 
nitrophenyl phosphate, and several different phosphotyrosine 
peptide and protein substrates (42).
























heart was similar to that reported for preparations from other 
tissues (3, 6). In the absence of Mn2+, the dephosphorylation 
of Rn was completely dependent on Ca2+ and calmodulin, with 
half-maximal activation occurring at 3 nM calmodulin (data 
not shown). In the presence of 2 mM Mn2+, the rate of 
dephosphorylation was only partially dependent on calmod­
ulin; addition of 1 /nM calmodulin stimulated the enzyme 4­
5-fold. The maximal rate of Rn dephosphorylation was ob­
served with 2 mM Mn2+, 1 fiM calmodulin. The rate of de­
phosphorylation observed with 100 tiM Ca2+, 1  nM calmodulin, 
and no added Mn2+ was approximately 4-fold lower than this 
rate.
A number of different agents were tested for their ability 
to inhibit dephosphorylation of Rn (Table I). EGTA (2 mM) 
inhibited Rn dephosphorylation completely, indicating the 
importance of metal ions such as Ca2+ or Mn2+ in the reaction. 
Low concentrations of lanthanum chloride (100 mm) also 
inhibited dephosphorylation of Rn, but the mechanism of this 
inhibition is not clear. At the concentrations of La3+ used, it 
probably binds to both calmodulin and the B subunit of the 
enzyme. Lanthanum ion may also interact with the catalytic 
site of the enzyme since other metal ions are known to interact 
with this site (20-25). Trifluoperazine, a widely used calmod­
ulin antagonist, effectively inhibited Rn dephosphorylation 
(~90% inhibition at 100 /*M trifluoperazine, 1 ^M calmodulin). 
Inorganic phosphate was also an effective inhibitor (complete 
inhibition of Rn dephosphorylation was achieved with 50 mM 
phosphate), but sodium fluoride was not found to inhibit Rn 
dephosphorylation significantly at concentrations as high as 
3 mM.
The catalytic subunit of the cAMP-dependent protein ki­
nase also effectively prevented Rn dephosphorylation when 
present at concentrations equal to those of Rn. Presumably 
this is because the kinase catalytic subunit binds Rn in the 
vicinity of the phosphorylation site and thereby prevents 
access by the phosphatase. Similar effects of the kinase cat­
alytic subunit on Rn dephosphorylation have been observed 
with other protein phosphatases (26, 27) and may be of 
physiological significance with respect to the regulation of Rn 
dephosphorylation. The report that calcineurin binds to the 
holoenzyme form of brain cAMP-dependent protein kinase 
(7) suggests that this isozyme of Rn contains two distinct 
interaction sites for calcineurin. This does not appear to be 
the case for cardiac Rn since attempts to demonstrate complex 
formation between calcineurin, calmodulin, and reconstituted
T a b l e  I
Effect of various inhibitors on Rn dephosphorylation by cardiac 
calmodulin-dependent phosphatase
Inhibitor" Concentration % inhibition
Sodium fluoride 0.3 mM 3
1.0 mM 0
3.0 mM 10
Sodium phosphate6 50 mM 100
C-subunit (equimolar to Rn) 94
Trifluoperazine 1 n  M 10
10  )lM 51
100 /iM 87
EGTA or EDTA" 2 mM 100
LaCla 100 #iM 50
1 mM 100
heart Type II protein kinase were unsuccessful (28).
Dephosphorylation of Rrr Fragments—Because the struc­
tural basis for the narrow substrate specificity of the calmod­
ulin-dependent phosphatase is not well understood, it was of 
interest to prepare different proteolytic fragments of Rn to 
determine which features of structure might be important for 
recognition by the phosphatase. Previous studies (18, 29-31) 
have described the preparation and characterization of bovine 
cardiac Rn fragments using different proteolytic enzymes. Fig. 
1  shows a diagram indicating the sites of proteolysis obtained 
when limiting amounts of different proteases are used. Chy- 
motrypsin and trypsin cleave at sites just to the amino ter­
minal side of Ser-95 and yield phosphorylated fragments 
which have molecular weights (using polyacrylamide gel elec­
trophoresis in the presence of sodium dodecyl sulfate) of 
approximately 37,000 (17, 30, 31). Both cAMP-binding do­
mains are contained within these fragments (29, 32). Limited 
proteolysis with Staphylococcal aureus V8 protease cleaves 
after Glu-99 yielding a phosphorylated fragment which has 
an apparent molecular weight of 17,000 by gel electrophoresis 
and which consists of the amino terminal 99 residues of Rn 
(17, 31).
Patterns of proteolysis similar to those previously reported 
were obtained in the present study, except that more extensive 
digestion was obtained using S. aureus protease. Phosphopep- 
tides from each proteolytic digestion were separated by gel 
filtration chromatography (Fig. 2) and analyzed by polyacryl­
amide gel electrophoresis in the presence of sodium dodecyl 
sulfate. In the case of trypsin and chymotrypsin, the peaks 
indicated as being pooled in Fig. 2 exhibited apparent Mr of 
~37,000 by gel electrophoresis (data not shown). With S. 
aureus protease three peaks of radioactivity were pooled which 
showed apparent Mr values on electrophoretic gels ranging 
from 2,000 (peak III) to 17,000 (peak I) (data not shown). The 
various pooled peaks shown in Fig. 2 were assayed for their 
ability to serve as substrates for the calmodulin-dependent 
phosphatase (Table II). The trypsin fragment was the poorest 
substrate, followed by the chymotrypsin fragment. Interest­
ingly, all three fragments obtained by S. aureus protease 
digestion were dephosphorylated as rapidly as intact Rn.
Because all of the determinants for substrate specificity 
appeared to be present in the shortest fragment from S. aureus 
protease digestion (peak III), this material was subjected to 
more detailed investigation and peaks I and II from S. aureus 
protease digestion were not further characterized. The gel 
filtration pool containing the smallest fragment was subjected 
to purification by reversed-phase high performance liquid 
chromatography (Fig. 3). Although a number of peptides were 
present in the pool, only one had significant amounts of 32P 
associated with it (Fig. 3). The high performance liquid chro­
matography fraction containing this peptide was subjected to
C T ^  S





“ Dephosphorylation of 32P-Rn was performed as described under 
“Materials and Methods.” The concentration of 32P-Rn and calmod­
ulin in the reaction were 10  /iM and 1  fiM, respectively.
b The pH of the sodium phosphate solution was adjusted to 7.0 
before adding to the assay mixture.
c The reaction mixture contained 2 mM Mg2-1-, but Mn2+ and Ca2+ 
were omitted.
Staph, aureus V8 protease {1 *99 )
P ig . 1. S ites of lim ited proteolysis in  phospho-Rn. The se­
quence around the autophosphorylation site of Rn (Ser 95) is shown 
with arrows indicating cleavage sites following proteolysis of auto- 
phosphorylated Rn with chymotrypsin (C), trypsin (T), and S. aureus 

























Fragment Relative rate of dephos­phorylation
Trypsin < 0.01
Chymotrypsin 0.08
S. aureus protease peak I 1.0
S. aureus protease peak II 1.0
S. aureus protease peak III 1.0
F ig . 2. G -75 chrom atography of Rn proteolytic fragm ents.
Following limited proteolytic digestion, samples were applied to G-75 
(2.5 X 90 cm) equilibrated in 0.3 M ammonium acetate, pH 7.0, 15 
mM (3-mercaptoethanol, and the fractions (8 ml each) indicated by 
bars were pooled and lyophilized. Limited tryptic digestion was per­
formed using a trypsin (L-l-tosyl-amido-2-phenylethyl chloromethyl 
ketone-trypsin, Worthington): 32P-Rn ratio of 1:1000 (w/w) at 21°C 
for 5 min. Tosyl-L-lysine chloromethyl ketone (Sigma) and soybean 
trypsin inhibitor (Calbiochem-Behring) were used to stop proteolysis 
before chromatography. Proteolysis with a-chymotrypsin (Worthing­
ton) was performed on ice for 75 min at an enzyme/substrate ratio of 
1:500 (w/w). Proteolysis was stopped by adding tosylamide 2-phen- 
ylethyl chloromethyl ketone (Sigma) and soybean trypsin inhibitor. 
Digestion with S. aureus V8 protease (Miles; enzyme/substrate ratio 
of 1:25) was allowed to proceed for 2 h on ice before adding phenyl­
methylsulfonyl fluoride (Sigma). The mixture was applied to a small 
column (0.7 X 24 cm) of cAMP-(N-6)-agarose (P-L Biochemicals) 
and the flow-through fractions applied to G-75. Pool I was used to 
obtain the data shown in Table II.
T a b l e  II
Dephosphorylation of Rn proteolytic fragments 
Fragments were generated with the indicated protease and were 
purified by gel filtration chromatography (Fig. 2), dried under vac­
uum, and redissolved to give a final concentration of 8 uM in the 
dephosphorylation reaction. Rates of dephosphorylation of the frag­
ments were determined as described under “Materials and Methods” 
and are reported relative to the rate of intact Rn dephosphorylation.
F ig . 3. R eversed-phase high perform ance liquid chrom a­
tography purification  of G -75 peak  III  from  S. aureus p ro ­
tease digestion. A sample (150 jul) from the pooled fractions indi­
cated as peak III (Fig. 2, bottom panel) was applied to a Varian 
MicroPak MCH-10 reversed-phase column (0.8 X 50 cm, C-18). A 
gradient from 0.1% trifluoroacetic acid/H20  to 60% of 0.08% trifluo- 
roacetic acid/CH3CN over 30 min (flow rate = 2 ml/min) was used 
to develop the chromatogram. Absorbance at 206 nm (solid line) was 
used to monitor eluted material, and fractions were collected by hand 
into scintillation vials for detection of 32P by Cerenkov radiation 
(cross-hatched area). Fraction 23 contained 73% of all radioactivity 
collected (217,000 cpm by Cerenkov). This fraction was submitted for 
amino acid composition and sequence analysis.
T a b l e  III
Kinetic parameters for dephosphorylation of synthetic Ru 
phosphopeptides by cardiac calmodulin-dependent phosphatase 
Phosphatase assays were performed in duplicate as described under 
“Materials and Methods” except that 100-ftl reaction volumes were 
used. Samples (20 pi each) were removed at three time points (typi­
cally 5, 10, and 20 min) to determine reaction rates and to assure 
that linear rates were maintained throughout the course of the reac­
tion. Another aliquot (20 til) was removed and counted to determine 
substrate concentration. Kinetic parameters were determined graph­
ically from double-reciprocal plots.
Peptide sequence" Km V J * .
flM nmol/mining
DRRVSVAAE 400 130 0.32
FDRRVSVAAE 210 130 0.62
PIPGRFDRRVSVAAE 130 240 1.8
DLDVPIPGRFDRRVSVAAE 26 1700 65
RII 20 2000 100
amino acid composition and sequence analysis and found to 
have the following sequence: Asp-Leu-Asp-Val-Pro-Ile-Pro- 
Gly-Arg-Phe-Asp-Arg-Arg-Val-Ser-Val-Cys-Ala-Glu. This is 
the smallest phosphopeptide expected from Rn using S. aureus 
protease (17).
Dephosphorylation of Synthetic Phosphopeptides—In order 
to define the minimum primary structure required for recog­
nition by the calmodulin-dependent phosphatase, a series of
“ One-letter designations for amino acids are given in the legend to 
Fig. 4.
synthetic phosphopeptides were prepared. The kinetic param­
eters for these peptides are shown in Table III. The longest 
peptide synthesized corresponds in sequence to the 19-residue 
peptide fragment generated by S. aureus protease (i.e. peak 
III), except that Cys-97 has been replaced by alanine. The 
dephosphorylation of this peptide exhibits kinetic constants 
that are comparable to those observed for intact Rn. Reducing 
the length at the N terminus by 4 residues markedly reduces 
the rate at which the peptide is dephosphorylated. Both the 



























continues to alter both Km and V values. The large differ­
ence in substrate competence observed between the 15- and 
19-residue peptides (about a 30-fold difference in Km/V msa 
ratio) is particularly interesting considering that the addi­
tional residues of the longer peptide are more than 10 residues 
away from the phosphoserine residue.
DISCUSSION
An important biochemical feature of the calmodulin-de­
pendent protein phosphatase is its high degree of substrate 
specificity (2, 3, 19). Several lines of evidence suggest that 
higher order structure is an important determinant of sub­
strate specificity for this enzyme. Comparison of the amino 
acid sequences of phosphorylation sites in phosphoproteins 
that are good substrates for this enzyme and those that are 
poor does not indicate any consistent features of primary 
structure which might be important for substrate recognition. 
Basic amino acid residues close to the phosphorylated residue 
are found in most of the good substrates but also in several 
phosphoproteins which are not good substrates. Three of the 
best substrates, phosphatase inhibitor-1, DARPP-32, and G- 
substrate, have homologous sequences that are somewhat 
unusual in that proline residues are found adjacent to the 
phosphorylation sites in these proteins and in that the phos­
phorylated residue is threonine (19, 33). Interestingly, G- 
substrate has two such sites that are dephosphorylated at 
quite different rates (approximately 20-fold) by the calmod­
ulin-dependent phosphatase (19). The 12 residues immedi­
ately surrounding the two phosphorylation sites differ by only 
one amino acid (33). Moreover, other enzymes acting on these 
phosphorylation sites, including other type 2 protein phos­
phatases (19) and cGMP-dependent protein kinase (33), show 
little or no preference for either site. Taken together with the 
results in the present report, these data support the idea that 
higher order structures are important determinants for sub­
strate recognition by the calmodulin-dependent protein phos­
phatase.
Structural analysis of the autophosphorylation site in Rn 
may indicate features of higher order structure important for 
substrate recognition, particularly when considered in relation 
to data obtained with synthetic phosphopeptide substrates. A 
structural profile for the shortest peptide sequence giving 
optimal kinetic constants (Rn peptide 81-99) is shown in Fig. 
4. Secondary structural predictions based on Chou-Fasman 
probabilities (34-36) indicate a high probability of /3-turn in 
the region containing the two prolyl residues. Immediately C- 
terminal to this region is a short segment predicted to form 
/3-strand. The very C terminus might form a-helix, although 
it would probably be unstable since only one turn of helix is 
predicted. NMR studies by Rosevear and co-workers (38) 
using a synthetic heptapeptide (Leu-Arg-Arg-Ala-Ser-Leu- 
Gly) with a sequence very similar to the sequence around the 
phosphorylation site in Rn indicate that an extended coil 
structure is likely to occur in this region of the molecule. The 
amino terminus of the nonadecapeptide appears to have no 
strong propensity for any periodic secondary structure as 
determined by Chou-Fasman analysis; however, consideration 
of the peptide’s hydrophobicity profile (Fig. 4, bottom panel) 
indicates that the amino terminus might form a /3-strand 
since alternating hydrophobic and hydrophilic residues are 
often found in /3-strands at the surface of proteins (37, 39). 
The predicted occurrence of the secondary structural sequence 
/3-strand, /3-turn, /3-strand indicates that the amino terminus 
of the nonadecapeptide might form a small segment of am- 
phipathic antiparallel /3-sheet structure. Although this struc­
tural model is tentative, it is strongly supported by data from
Fig. 4. S tru c tu ra l analysis of Rn phosphopeptide from  S. 
aureus p ro tease digestion. Chou-Fasman probabilities (34), aver­
aged over 4 residues, were calculated for a-helix (O----- O), /3-strand
(O-----O), and /3-turn (• • • • ) using the program of Corrigan and
Huang (35) and data from Argos et al. (36). Bulk hydrophobicity 
values (37) were plotted without averaging (bottom panel). The pep­
tide sequence is shown between the top and bottom panels using the 
following one-letter codes to designate each amino acid: A (alanine), 
R (arginine), D (aspartic acid), C (cysteine), E (glutamic acid), G 
(glycine), I  (isoleucine), L (leucine), F (phenylalanine), P  (proline), 
S (serine), and V (valine).
the dephosphorylation of the synthetic phosphopeptides (Ta­
ble II). The 19-residue synthetic phosphopeptide, which is 
presumably capable of forming the proposed /3-sheet structure, 
is a much better substrate than the 15-residue peptide which 
lacks the 4 residues necessary for completing the /3-sheet. 
Considering that these 4 critical residues are quite distant in 
linear sequence from the phosphoseryl residue and that they 
only increase the size of the peptide by about 25% lends 
support to the argument that these residues are important 
because of their participation in some sort of higher order 
structure.
Although the calmodulin-dependent phosphatase shows a 
high degree of substrate specificity with respect to phosphos­
eryl and phosphothreonyl substrates, data from studies using 
several different phosphotyrosyl substrates of known se­
quence indicate a relative lack of specificity (42). Interest­
ingly, a synthetic phosphopeptide corresponding in sequence 
to the best synthetic peptide employed in the present study, 
but containing phosphotyrosyl in place of phosphoseryl, was 
no better a substrate than any of the other phosphotyrosyl 
substrates examined. Thus, the structural determinants im­
portant for substrate specificity appear to depend upon the 
nature of the phosphorylated residue in the protein or peptide.
Only a limited amount of data is available regarding the 
substrate specificities of other protein phosphatases using 
synthetic phosphopeptide substrates (16, 40, 41). The data 
from these various studies suggest that higher order structures 
may not be important determinants for these other phospha­
tases, since short peptides were readily dephosphorylated by 
the enzymes used in those studies. However, a number of 
phosphoprotein phosphatases have recently been described 
that have not been extensively studied using synthetic phos­
























quirements that involve higher order structure. It will be 
interesting to study these various enzymes by techniques 
similar to those described here to determine whether or not 
this is the case.
In summary, the data obtained using autophosphorylated 
Rn as a model substrate indicate that the basis for the cal­
modulin-dependent protein phosphatase’s high degree of sub­
strate specificity may be a requirement for higher order struc­
ture. In the case of Rn, the higher order structure involved 
appears to be a small region of /3-sheet adjacent to the phos­
phorylation site. Future experiments involving structural and 
enzymological characterization of other substrates for this 
enzyme should clarify whether this is a general structural 
feature required for substrate recognition.
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